ROME — The head of Italy’s pharmacological agency says there is little data about the effectiveness of the anti-malaria drug promoted by U.S. President Donald Trump to treat coronavirus.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=1310414
Well, Italian Hydroxychloroquin, sure thing.
But good old USA Hydroxychloroquin, safe as hell, even at double dosage.
Dr. Stable von Jenius is heavily invested in its success.
3 Likes
And another reputable source advising against the use of hydroxychloroquine as a prophylactic for COVD-19. Too bad it will not be accepted.
